Group One Trading, L.P. Lumos Pharma, Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	BUY	$13.61 - $35.91 $2,041 - $5,386	150 New	150 $5,000
Q3 2020 Nov 12, 2020	SELL	$13.25 - $16.5 $68,860 - $85,750	-5,197 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$7.76 - $16.99 $3,274 - $7,169	422 Added 8.84%	5,197 $86,000
Q1 2020 May 13, 2020	BUY	$0.89 - $8.85 $4,249 - $42,258	4,775 New	4,775 $41,000

2.2M

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $36.4M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.